An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population With Diabetes and Ischemic Cardio-Cerebrovascular Disease

Launched by GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Jul 29, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at people who have both type 2 diabetes and heart or brain blood vessel problems, such as those caused by a stroke or heart disease. The study aims to understand patterns of symptoms and health changes based on traditional Chinese medicine (TCM) ideas. Researchers want to find which symptom patterns are linked to higher risks and how these patterns change over time, especially during important stages like sudden illness, recovery, and serious health events.

Adults aged 18 and older who have both type 2 diabetes and related heart or brain blood vessel conditions may be able to join, as long as they don’t have active infections, cancer, autoimmune diseases, or severe mental health issues that affect their ability to report symptoms. Participants will be followed over time to track their symptoms and health changes, helping doctors better understand how these conditions interact and evolve according to TCM perspectives. The study is not yet recruiting, but it hopes to provide useful information for managing people with these combined health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years Diagnosed with comorbidities relevant to "toxin-damaged collaterals" theory (e.g., type 2 diabetes mellitus with cardiovascular/cerebrovascular disease).
• • Voluntary participation with signed informed consent.
• Exclusion Criteria:
• • Acute infectious diseases, malignant tumors, or autoimmune disorders. Mental illness or cognitive impairment affecting symptom assessment.